Home/Filings/4/0001493152-21-008569
4//SEC Filing

Daniel Jeremy 4

Accession 0001493152-21-008569

CIK 0001591165other

Filed

Apr 11, 8:00 PM ET

Accepted

Apr 12, 5:19 PM ET

Size

5.9 KB

Accession

0001493152-21-008569

Insider Transaction Report

Form 4
Period: 2021-04-01
Daniel Jeremy
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-04-01+5,000,0005,000,000 total
    Exercise: $0.07Exp: 2031-04-01Common Stock (5,000,000 underlying)
Footnotes (1)
  • [F1]On April 1, 2021, Hy-Cyte, Inc. (the "Company) issued to Jeremy Daniel options (the "Options") to purchase 5,000,000 shares of the Company's common stock at an exercise price of $0.07. The Options shall be exercisable with respect to 25% of the Option Shares on the twelve (12) month anniversary of the Date of Grant, and the remaining 75% of the Option Shares shall become exercisable in 12 equal quarterly installments thereafter on the final day of each fiscal quarter, in each case, so long as Mr. Daniel remains an employee of the Company or a subsidiary thereof on each such date.

Documents

1 file

Issuer

H-CYTE, INC.

CIK 0001591165

Entity typeother

Related Parties

1
  • filerCIK 0001767519

Filing Metadata

Form type
4
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 5:19 PM ET
Size
5.9 KB